Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies

被引:13
作者
Blanchard, S
Astier-Gin, T
Tallet, B
Moynet, D
Londos-Gagliardi, D
Guillemain, B
机构
[1] Univ Victoria Segalen Bordeaux 2, IBGC, CNRS, EP630, F-33077 Bordeaux, France
[2] Univ Victor Segalen Bordeaux 2, Virol Lab, F-33076 Bordeaux, France
[3] Univ Victor Segalen Bordeaux 2, Immunol Lab, F-33076 Bordeaux, France
关键词
D O I
10.1128/JVI.73.11.9369-9376.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The nucleotide sequence of human T-cell leukemia virus type 1 (HTLV-1) is highly conserved, most strains sharing at least 95% sequence identity. This sequence conservation is also found in the viral env gene, which codes for the two envelope glycoproteins that play a major role in the induction of a protective immune response against the virus. However, recent reports have indicated that some variations in env sequences may induce incomplete cross-reactivity between HTLV-1 strains. To identify the amino acid changes that might be involved in the antigenicity of neutralizable epitopes, we constructed expression vectors coding for the envelope glycoproteins of two HTLV-1 isolates (2060 and 2072) which induced human antibodies with different neutralization patterns. The amino acid sequences of the envelope glycoproteins differed at four positions. Vectors coding for chimeric or point-mutated envelope proteins were derived from 2060 and 2072 HTLV-1 env genes. Syncytium formation induced by the wild-type or mutated envelope proteins was inhibited by human sera with different neutralizing specificities. We thus identified two amino acid changes, 1173 --> V and A187 --> T, that play an important role in the antigenicity of neutralizable epitopes located in this region of the surface envelope glycoprotein.
引用
收藏
页码:9369 / 9376
页数:8
相关论文
共 43 条
[1]   Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states [J].
AstierGin, T ;
Portail, JP ;
LondosGagliardi, D ;
Moynet, D ;
Blanchard, S ;
Dalibart, R ;
Pouliquen, JF ;
GeorgesCourbot, MC ;
Hajjar, C ;
SainteFoie, S ;
Guillemain, B .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) :716-719
[2]  
BABA E, 1993, J IMMUNOL, V151, P1013
[3]  
BABA E, 1995, J IMMUNOL, V154, P399
[4]   CROSS-NEUTRALIZING ANTIBODIES AGAINST COSMOPOLITAN AND MELANESIAN STRAINS OF HUMAN T-CELL LEUKEMIA/LYMPHOTROPIC VIRUS TYPE-I IN SERA FROM INHABITANTS OF AFRICA AND THE SOLOMON-ISLANDS [J].
BENSON, J ;
TSCHACHLER, E ;
GESSAIN, A ;
YANAGIHARA, R ;
GALLO, RC ;
FRANCHINI, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (01) :91-96
[5]   Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I [J].
Blanchard, S ;
Astier-Gin, T ;
Moynet, D ;
Edouard, E ;
Guillemain, B .
VIROLOGY, 1998, 245 (01) :90-98
[6]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[7]   IDENTIFICATION OF FUNCTIONAL REGIONS IN THE HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I SU GLYCOPROTEIN [J].
DELAMARRE, L ;
PIQUE, C ;
PHAM, D ;
TURSZ, T ;
DOKHELAR, MC .
JOURNAL OF VIROLOGY, 1994, 68 (06) :3544-3549
[8]   A novel human T-Leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity [J].
Delamarre, L ;
Rosenberg, AR ;
Pique, C ;
Pham, D ;
Dokhelar, MC .
JOURNAL OF VIROLOGY, 1997, 71 (01) :259-266
[9]   INFLUENCE OF TRANSMEMBRANE DOMAINS ON THE FUSOGENIC ABILITIES OF HUMAN AND MURINE LEUKEMIA RETROVIRUS ENVELOPES [J].
DENESVRE, C ;
SONIGO, P ;
CORBIN, A ;
ELLERBROK, H ;
SITBON, M .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4149-4157
[10]   IDENTIFICATION OF NOVEL NEUTRALIZATION-INDUCING REGIONS OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I ENVELOPE GLYCOPROTEINS WITH HUMAN HTLV-I-SEROPOSITIVE SERA [J].
DESGRANGES, C ;
SOUCHE, S ;
VERNANT, JC ;
SMADJA, D ;
VAHLNE, A ;
HORAL, P .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) :163-173